4D Molecular Therapeutics (FDMT) Stock Chart & Stock Price History → Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (From InvestorPlace) (Ad) Free FDMT Stock Alerts $25.90 +0.20 (+0.78%) (As of 02:21 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media 4D Molecular Therapeutics Stock Price Performance5 Day Performance-1.63%1 Month Performance-1.71%3 Month Performance-2.81%6 Month Performance+145.96%Year-To-Date Performance+27.84%1 Year Performance+44.61% Receive FDMT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI BreakthroughsWhile gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action FDMT Stock Chart for Monday, May, 13, 2024 FDMT Chart by TradingView 4D Molecular Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$25.64$25.70+0.23%$26.24$24.27397,446 shs$1.31 billion05/09/2024$26.33$25.64-2.62%$26.85$25.54322,984 shs$1.31 billion05/08/2024$26.80$26.33-1.75%$26.78$25.90340,145 shs$1.35 billion05/07/2024$26.76$26.80+0.15%$27.09$26.26334,994 shs$1.37 billion05/06/2024$26.38$26.76+1.44%$27.00$26.41371,209 shs$1.37 billion05/03/2024$26.38$26.38$27.84$26.20320,319 shs$1.35 billion Get the Latest News and Ratings for FDMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$25.39$26.38+3.90%$26.54$24.93456,873 shs$1.35 billion05/01/2024$23.93$25.39+6.10%$26.59$24.00649,701 shs$1.30 billion04/30/2024$24.25$23.93-1.32%$24.56$23.57359,827 shs$1.22 billion04/29/2024$23.25$24.25+4.30%$24.66$23.47315,391 shs$1.24 billion04/26/2024$23.53$23.25-1.19%$23.86$22.75322,774 shs$1.19 billion04/25/2024$24.25$23.53-2.97%$23.98$22.91453,265 shs$1.20 billion04/24/2024$24.81$24.25-2.26%$25.38$24.23290,423 shs$1.24 billion04/23/2024$26.39$24.81-5.99%$26.84$24.69565,554 shs$1.27 billion04/22/2024$25.25$26.39+4.51%$26.92$24.57484,648 shs$1.35 billion04/19/2024$24.78$25.25+1.90%$25.56$24.38634,769 shs$1.29 billion04/18/2024$25.30$24.78-2.06%$25.27$24.71417,554 shs$1.27 billion04/17/2024$26.75$25.30-5.42%$26.99$25.15519,112 shs$1.29 billion04/16/2024$26.25$26.75+1.90%$27.24$25.74477,002 shs$1.37 billion04/15/2024$26.35$26.25-0.38%$27.97$25.94610,526 shs$1.34 billion04/12/2024$27.70$26.35-4.87%$27.72$26.09401,322 shs$1.31 billion04/11/2024$26.93$27.70+2.86%$27.87$26.60649,445 shs$1.38 billion04/10/2024$27.10$26.93-0.63%$27.29$25.68520,160 shs$1.34 billion04/09/2024$28.75$27.10-5.74%$29.21$26.80545,301 shs$1.35 billion04/08/2024$28.60$28.75+0.52%$29.27$28.12555,663 shs$1.43 billion04/05/2024$27.64$28.60+3.47%$28.71$26.90367,185 shs$1.42 billion04/04/2024$27.92$27.64-1.00%$28.86$27.42641,307 shs$1.38 billion04/03/2024$27.98$27.92-0.21%$28.09$27.00661,127 shs$1.39 billion04/02/2024$30.01$27.98-6.76%$29.66$27.462.01 million shs$1.39 billion04/01/2024$31.86$30.01-5.81%$31.87$28.801.07 million shs$1.49 billion03/29/2024$31.86$31.86$34.20$30.251.61 million shs$1.59 billion03/28/2024$35.87$31.86-11.18%$34.20$30.251.60 million shs$1.59 billion03/27/2024$34.05$35.87+5.35%$36.25$33.93723,427 shs$1.79 billion03/26/2024$33.60$34.05+1.34%$34.71$33.16487,821 shs$1.70 billion03/25/2024$33.60$33.60$34.18$33.40297,367 shs$1.67 billion03/22/2024$33.80$33.60-0.59%$33.95$32.90302,107 shs$1.67 billion03/21/2024$33.50$33.80+0.90%$34.28$33.55665,603 shs$1.68 billion03/20/2024$32.02$33.50+4.62%$33.93$31.37481,422 shs$1.67 billion03/19/2024$31.03$32.02+3.19%$32.09$29.23796,243 shs$1.59 billion03/18/2024$31.51$31.03-1.52%$31.91$30.45778,774 shs$1.54 billionThis 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here03/15/2024$29.37$31.51+7.29%$32.37$28.801.55 million shs$1.57 billion03/14/2024$29.40$29.37-0.10%$29.59$28.29855,433 shs$1.46 billion03/13/2024$28.53$29.40+3.05%$29.58$28.53437,195 shs$1.46 billion03/12/2024$28.55$28.53-0.07%$28.94$27.51458,655 shs$1.42 billion03/11/2024$29.57$28.55-3.45%$30.15$28.33646,599 shs$1.42 billion03/08/2024$29.51$29.57+0.20%$31.16$28.50702,045 shs$1.47 billion03/07/2024$28.26$29.51+4.42%$29.66$28.00686,282 shs$1.47 billion03/06/2024$27.04$28.26+4.51%$28.27$27.00432,768 shs$1.41 billion03/05/2024$28.74$27.04-5.92%$29.14$27.00596,876 shs$1.35 billion03/04/2024$29.37$28.74-2.15%$29.95$28.512.45 million shs$1.23 billion03/01/2024$28.02$29.37+4.82%$29.91$27.65865,487 shs$1.26 billion02/29/2024$27.89$28.02+0.47%$29.13$27.85477,076 shs$1.20 billion02/28/2024$29.91$27.89-6.75%$29.91$27.80438,862 shs$1.19 billion02/27/2024$29.00$29.91+3.14%$30.23$29.02940,644 shs$1.28 billion02/26/2024$27.19$29.00+6.66%$29.13$27.13543,079 shs$1.24 billion02/23/2024$26.18$27.19+3.86%$27.58$26.24649,146 shs$1.16 billion02/22/2024$26.48$26.18-1.13%$27.05$26.00719,325 shs$1.12 billion02/21/2024$27.39$26.48-3.32%$27.86$26.29683,272 shs$1.13 billion02/20/2024$27.26$27.39+0.48%$27.70$26.751.01 million shs$1.17 billion02/19/2024$27.26$27.26$28.18$27.25853,100 shs$1.17 billion02/16/2024$27.69$27.26-1.55%$28.18$27.25853,177 shs$1.17 billion02/15/2024$27.81$27.69-0.43%$28.62$27.67936,668 shs$1.18 billion02/14/2024$26.65$27.81+4.35%$28.02$26.051.15 million shs$1.19 billion02/13/2024$27.85$26.65-4.31%$27.35$26.251.03 million shs$1.14 billion02/12/2024$28.63$27.85-2.72%$29.32$27.281.93 million shs$1.19 billion Related Companies: VIR Stock Price Chart TARS Stock Price Chart CGEM Stock Price Chart NMRA Stock Price Chart SRRK Stock Price Chart ADMA Stock Price Chart BCRX Stock Price Chart AUTL Stock Price Chart INBX Stock Price Chart FUSN Stock Price Chart Receive FDMT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FDMT) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorBill Clinton Backing Biden Replacement???The Freeport SocietyUrgent Nvidia WarningAltimetryThis 1 Biotech Stock has been shocking the marketsHuge AlertsHow Biden has already won 2024Porter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D Molecular Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.